Clifford L. Cua

Dr. Clifford L. Cua

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MGMark Galantowicz
Mark Galantowicz
JCJohn P. Cheatham
John P. Cheatham
APAlistair Phillips
Alistair Phillips
CCClifford L. Cua
Clifford L. Cua
THTimothy M. Hoffman
Timothy M. Hoffman
RRRoberta Rodeman
Roberta Rodeman

1 July 2006 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
AYAndrew R. Yates
Andrew R. Yates
PDPeter C. Dyke
Peter C. Dyke
RTRoozbeh Taeed
Roozbeh Taeed
THTimothy M. Hoffman
Timothy M. Hoffman
JHJohn Hayes
John Hayes
CCClifford L. Cua
Clifford L. Cua
Hyperglycemia in critical care populations has been shown to be a risk factor for increased morbidity and mortality. Minimal data exist in postoperative pediatric cardiac patients. The goal of this study was to determine whether hyperglycemia in the postoperative period was associated with increased morbidity or mortality. Retrospective chart review. Tertiary care, free-standing pediatric medical center with a dedicated cardiac intensive care unit. We included 184 patients <1 yr of age who underwent cardiac surgery requiring cardiopulmonary bypass from October 2002 to August 2004. Patients with a weight <2 kg, a preoperative diagnosis of diabetes, preoperative extracorporeal membrane oxygenation support, solid organ transplant recipients, and preoperative renal or liver insufficiency were excluded. None. Age was 4.3 ± 3.2 months and weight was 4.9 ± 1.7 kg at surgery. Duration of hyperglycemia was significantly longer in patients with renal insufficiency (p = .029), liver insufficiency (p = .006), infection (p < .002), central nervous system event (p = .038), extracorporeal membrane oxygenation use (p < .001), and death (p < .002). Duration of hyperglycemia was also significantly associated with increased intensive care (p < .001) and hospital (p < .001) stay and longer ventilator use (p < .001). Peak glucose levels were significantly different in patients with renal insufficiency (p < .001), infection (p = .002), central nervous system event (p = .01), and mortality (p < .001). Hyperglycemia in the postoperative period was associated with increased morbidity and mortality in postoperative pediatric cardiac patient. Strict glycemic control may improve outcomes in this patient population.

31 January 2023 in Circulation
Verified
Journal Article
Open access
KDKonstantinos Dimopoulos
Konstantinos Dimopoulos
ACAndrew Constantine
Andrew Constantine
PCPaul Clift
Paul Clift
RCRobin Condliffe
Robin Condliffe
SMShahin Moledina
Shahin Moledina
CBCraig S. Broberg
Craig S. Broberg
Cardiovascular disease is a leading cause of morbidity and mortality in individuals with Down syndrome. Congenital heart disease is the most common cardiovascular condition in this group, present in up to 50% of people with Down syndrome and contributing to poor outcomes. Additional factors contributing to cardiovascular outcomes include pulmonary hypertension; coexistent pulmonary, endocrine, and metabolic diseases; and risk factors for atherosclerotic disease. Moreover, disparities in the cardiovascular care of people with Down syndrome compared with the general population, which vary across different geographies and health care systems, further contribute to cardiovascular mortality; this issue is often overlooked by the wider medical community. This review focuses on the diagnosis, prevalence, and management of cardiovascular disease encountered in people with Down syndrome and summarizes available evidence in 10 key areas relating to Down syndrome and cardiac disease, from prenatal diagnosis to disparities in care in areas of differing resource availability. All specialists and nonspecialist clinicians providing care for people with Down syndrome should be aware of best clinical practice in all aspects of care of this distinct population.

1 October 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CAChristine Ackerman
Christine Ackerman
ALAdam E. Locke
Adam E. Locke
EFEleanor Feingold
Eleanor Feingold
BRBenjamin Reshey
Benjamin Reshey
KEKarina Espana
Karina Espana
CMCheryl L. Maslen
Cheryl L. Maslen

5 May 2007 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
CCClifford L. Cua
Clifford L. Cua
ABA. Blankenship
A. Blankenship
ANA. L. North
A. L. North
JHJ. Hayes
J. Hayes
LNL. D. Nelin
L. D. Nelin

1 May 2006 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
CCClifford L. Cua
Clifford L. Cua
RTRavi R. Thiagarajan
Ravi R. Thiagarajan
KGKimberlee Gauvreau
Kimberlee Gauvreau
LLLillian Lai
Lillian Lai
JCJohn M. Costello
John M. Costello
PLPeter C. Laussen
Peter C. Laussen
Previous publications using nonconcurrent series of patients indicate improved survival for patients with hypoplastic left heart syndrome (HLHS) undergoing stage I palliation with a right ventricle to pulmonary artery conduit (NW-RVPA) vs. a modified Blalock-Taussig shunt (NW-BT). We compared postoperative outcomes in a concurrent series of patients with HLHS undergoing an NW-BT procedure vs. NW-RVPA procedure. Perioperative data from 66 consecutive patients who underwent NW-BT (n = 37) or NW-RVPA (n = 29) procedures were retrospectively analyzed. Cardiac intensive care unit in a tertiary pediatric hospital. Charts were reviewed for all patients with the diagnosis of HLHS undergoing the NW-BT or NW-RVPA procedure between January 2002 and December 2003. Cardiopulmonary bypass time was longer in the NW-BT group than in the NW-RVPA group (152.5 +/- 52.0 vs. 134.5 +/- 36.1 mins; p = .04). Postoperative diastolic pressures were higher and the Pao2 to Fio2 ratio profiles were lower for the NW-RVPA group over the first 72 hrs. Time to sternal closure (2 [1-6] vs. 4 [2-41] days; p = .01), duration of mechanical ventilation (113 [49-386] vs. 136 [84-764] hrs; p = .01), time to establish enteral feeds (4 [2-8] vs. 5 [3-22] days; p = .01), length of intensive care unit stay (11 [7-55] vs. 15 [8-90] days; p = .04), and length of hospital stay (16 [11-67] vs. 27 [12-126] days; p = .01) were shorter in the NW-RVPA group. Postoperative mortality was not significantly different between the NW-RVPA group (7%) and NW-BT group (11%). At an experienced institution with low stage I palliation mortality for HLHS, there were no differences in early morbidity and mortality between the NW-RVPA and NW-BT procedures. The primary advantage of the NW-RVPA procedure may be faster recovery following surgery and earlier discharge from the hospital.